Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Kiora Pharmaceuticals (KPRX) Shares Outstanding (Diluted Average) (2018 - 2026)

Kiora Pharmaceuticals filings provide 8 years of Shares Outstanding (Diluted Average) readings, the most recent being $4.1 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) fell 0.51% to $4.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.1 million, a 0.51% decrease, with the full-year FY2025 number at $4.1 million, down 0.51% from a year prior.
  • Shares Outstanding (Diluted Average) hit $4.1 million in Q4 2025 for Kiora Pharmaceuticals, down from $4.2 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $13.1 million in Q2 2022 to a low of $212612.0 in Q3 2021.
  • Median Shares Outstanding (Diluted Average) over the past 5 years was $3.9 million (2024), compared with a mean of $3.3 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): plummeted 97.2% in 2023 and later surged 1040.98% in 2024.
  • Kiora Pharmaceuticals' Shares Outstanding (Diluted Average) stood at $241099.0 in 2021, then surged by 203.74% to $732303.0 in 2022, then fell by 26.53% to $538007.0 in 2023, then soared by 666.73% to $4.1 million in 2024, then decreased by 0.51% to $4.1 million in 2025.
  • The last three reported values for Shares Outstanding (Diluted Average) were $4.1 million (Q4 2025), $4.2 million (Q3 2025), and $4.0 million (Q2 2025) per Business Quant data.